The trial will be conducted by the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes ...
Merck's animal health division, which develops vaccines and medicines for dogs, cats and cattle, posted nearly $1.4 billion in sales, up 9% from the same period a year ago. The company said higher ...
Merck issued guidance for 2025 that lags consensus amid struggles in China with Gardasil Merck's stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years ...
the successful launch of WINREVAIR and strong performance of our Animal Health business," said Robert Davis, chairman and chief executive officer, Merck. Also Read: RJK Jr.'s Involvement In Merck ...
The Food and Drug Administration approved Merck's vaccine designed to protect adults ... and those with chronic or immunocompromising health conditions are at increased risk for the illness ...